Universal CAR-T cell therapy
Standardized CAR-T cells from healthy donors could eventually make this powerful cancer therapy available to far more patients worldwide if researchers solve durability and rejection challenges.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic…
Blood tests show promise for catching pancreatic cancer earlier, though current evidence best supports their use alongside standard detection rather than as population screening alone.
Promising but preliminaryDapagliflozin improves left ventricular diastolic function and…
A common diabetes drug added to heart failure treatment reduces inflammation and improves heart function in a patient group with historically few medication options.
Promising but preliminaryEffects of tirzepatide on pancreatic beta-cell function in patients…
A newer diabetes medication substantially improves how well pancreas cells produce insulin compared to older treatments, offering meaningful metabolic advantage.
Promising but preliminaryTreatment of idiopathic pulmonary hemosiderosis in children
Rituximab shows potential as a steroid-sparing treatment for a rare but devastating childhood lung bleeding disease, though relapse rates highlight enormous remaining need.